Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Harries

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
BMJ (Clinical Research Ed.)|December 6, 2003
Near drowningMark Harries
The Lancet. Oncology|September 10, 2002
Part I: chemotherapy for epithelial ovarian cancer-treatment at first diagnosisMark Harries, Martin Gore
The Lancet. Oncology|September 10, 2002
Part II: chemotherapy for epithelial ovarian cancer-treatment of recurrent diseaseMark Harries, Martin Gore
Current Medicinal Chemistry|August 27, 2010
Recent advances in the discovery of selective AMPA receptor positive allosteric modulatorsSimon E Ward, Mark Harries
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Nanoparticle albumin-bound paclitaxel for metastatic breast cancerMark Harries, Paul Ellis, Peter Harper
Lancet (London, England)|August 23, 2005
Adjuvant trastuzumab for HER2-positive breast cancerJames Spicer, Mark Harries, Paul Ellis
Seminars in Oncology Nursing|November 26, 2023
Advanced Triple-Negative Breast CancerGrisma Patel, Alison Prince, Mark Harries
Biomed Research International|January 24, 2014
Targeting brain metastases in patients with melanomaDionysis Papadatos-Pastos, Aspasia Soultati, Mark Harries
Drugs|June 3, 2006
Albumin-bound Paclitaxel in metastatic breast cancer: viewpointsNeville Davidson, Nuhad Ibrahim, Mark Harries, et al.
British Journal of Pharmacology|April 29, 2010
Challenges for and current status of research into positive modulators of AMPA receptorsSimon E Ward, Benjamin D Bax, Mark Harries
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
BMJ (Clinical Research Ed.)|December 6, 2003
Near drowningMark Harries
The Lancet. Oncology|September 10, 2002
Part I: chemotherapy for epithelial ovarian cancer-treatment at first diagnosisMark Harries, Martin Gore
The Lancet. Oncology|September 10, 2002
Part II: chemotherapy for epithelial ovarian cancer-treatment of recurrent diseaseMark Harries, Martin Gore
Current Medicinal Chemistry|August 27, 2010
Recent advances in the discovery of selective AMPA receptor positive allosteric modulatorsSimon E Ward, Mark Harries
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Nanoparticle albumin-bound paclitaxel for metastatic breast cancerMark Harries, Paul Ellis, Peter Harper
Lancet (London, England)|August 23, 2005
Adjuvant trastuzumab for HER2-positive breast cancerJames Spicer, Mark Harries, Paul Ellis
Seminars in Oncology Nursing|November 26, 2023
Advanced Triple-Negative Breast CancerGrisma Patel, Alison Prince, Mark Harries
Biomed Research International|January 24, 2014
Targeting brain metastases in patients with melanomaDionysis Papadatos-Pastos, Aspasia Soultati, Mark Harries
Drugs|June 3, 2006
Albumin-bound Paclitaxel in metastatic breast cancer: viewpointsNeville Davidson, Nuhad Ibrahim, Mark Harries, et al.
British Journal of Pharmacology|April 29, 2010
Challenges for and current status of research into positive modulators of AMPA receptorsSimon E Ward, Benjamin D Bax, Mark Harries
Pageof 6